Delivery Order SPE2DB25D3404-SPE2DB26FULWW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $84,982.81 to AmerisourceBergen Drug Corp for the supply of Jadenu 360 mg tablets (30-count units) on October 15, 2025, with an ultimate completion date of October 16, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a $12,031.54 delivery order to AmerisourceBergen Drug Corp for Jadenu 360 mg tablets (30-count units) on October 24, 2025, with an ultimate completion date of October 27, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $16,490.00 by the Defense Logistics Agency's Medical Supply Chain for the supply of Jadenu 360 mg tablets (30-count units). The award, issued on June 2, 2025, with a completion date of June 3, 2025, represents a firm fixed-price contract with no set-aside designation, indicating competitive award. The point of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $28,728.06, is for the supply of JADENU 360 MG TABLET 30S, a specialty pharmaceutical product. The award has an ultimate completion date of October 16, 2024 and was made on October 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,475.44 firm fixed-price delivery order is for the supply of JADENU 360 MG TABLET 30S, a pharmaceutical product. The award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $42,178.14 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 4561654541 JADENU 360 MG TABLET 30S to an agency location in Conshohocken, Pennsylvania. Performance is required from July 31 through August 1, 2023. As a major distributor of pharmaceuticals and medical supplies for the Department of Defense, this order supports the Defense Logistics Agency's mission to provide...
- AmerisourceBergen Drug Corp received a $37,524.35 delivery order from the Defense Logistics Agency (DLA) on July 17, 2025, for the supply of Jadenu 360 mg tablets (30-count units). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by July 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Jadenu is an iron chelation therapy medication used to treat chronic iron overload, a condition common...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $20,139.12 firm fixed price contract is for the provision of JADENU 360 MG TABLET 30S, a pharmaceutical product. The delivery order has a completion date of December 21, 2023. Amerisourcebergen Drug Corp is a prime contractor that has previously received numerous federal contracts from DLA Troop Support Medical to supply...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit prime contractor, to provide JADENU 360 MG TABLET 30S at a potential value of $76,076.66. The contract has a completion date of March 5, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,439,641 units of the specialty medication JADENU 360 MG TABLET 30S. The $30,539.27 firm fixed-price contract has an ultimate completion date of August 14, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 DLA IDC through December 2025 for delivering a wide range...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB26FULWWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $21,735.08 to AmerisourceBergen Drug Corp for JADENU 360 mg tablets (30-count) on October 30, 2025, with completion scheduled for October 31, 2025. This firm fixed-price delivery order represents a non-competitive award under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate headquarters location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen serves the Defense Health Agency, military healthcare systems, and other government organizations through established contract vehicles. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC, designated SPE2DX, functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products, specialty medications, vaccines, and medical supplies to support military healthcare programs worldwide. The IDC represents DLA's pharmaceutical prime vendor strategy and demonstrates AmerisourceBergen's significant role in the federal medical supply chain serving defense and veteran healthcare needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.7k | 10/30/25 |